Skip to main content
OpenTrials

Clinical trial condition

Secondary Hypogammaglobulinemia

Explore clinical trials studying Secondary Hypogammaglobulinemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Secondary Hypogammaglobulinemia trial results

Active, Not Recruiting

COVID-19 Vaccine Responses in PIDD Subjects

NCT05321407

Conditions
Bruton type agammaglobulinemia, COVID-19, CVID, +22 more
Locations
  • University of South Florida St. Petersburg, Florida, United States
  • University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
  • Duke University Durham, North Carolina, United States
View Trial Details

Related conditions